In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 67 for your search:
Drug:  therapeutic autologous dendritic cells
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000068806, P30CA016042, UCLA-0001026, NCI-G01-1997, NCT00022334

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: ERLANGEN-1490, EU-20232, NCT00053391

3.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: over 18
Sponsor: Other
Protocol IDs: CDR0000270762, ERLANGEN-ONTAK, EU-20246, NCT00056134

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: ERLANGEN-DERMA-ER-DC-07, EU-20513, ARGOS-ERLANGEN-DERMA-DC-07, NCT00126685

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: RDA 0466, NCT00289341

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 21 to 75
Sponsor: Other
Protocol IDs: Baylor IRB #006-025-01, IND 12919, NCT00313235

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: RDA-0537, NCT00345293

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UR0414, NCT00197860

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: MM0413, NCT00197912

10.

Phase: Phase II, Phase I
Type: Diagnostic, Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: 2004-3126, KUN99-1950, NCT00243594

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CRITICAL001, NCT00753220

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 20 and over
Sponsor: Other
Protocol IDs: 198, NCT00795977

13.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 19 and over
Sponsor: Other
Protocol IDs: CAN-ONC-001 CAN, NCT00852007

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 19 months to 35 years
Sponsor: NCI
Protocol IDs: 070206, 07-C-0206, NCT00923351

15.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: NL22750.000.08, KUN2006-3699, NCT00940004

16.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Over 16
Sponsor: Other
Protocol IDs: CDR0000068481, HOAG-VACCINE-MEL, NCI-V01-1646, NCT00012064

17.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: ERLANGEN-DERMA-ER-DC-06, CDR0000343699, EU-20317, NCT00074230

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 35 and under at initial diagnosis
Sponsor: NCI
Protocol IDs: 970052, 97-C-0052, NCI-97-C-0052, NCI-T96-0038, T96-0038, NCT00019266, NCT00001566

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: CDR0000067277, NCI-99-C-0132, NCT00019890

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 990137, 99-C-0137, NCI-99-C-0137, NCI-NMOB-9903, NCI-T99-0074, T99-0074, NCT00019903, NCT00001827

21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2012-02427, UCSF-0155-01, NCI-2617, UCSF-01554, CDR0000069047, 2617, NCT00027599

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000370794, R01CA095648, P30CA023108, DMS-0238, DMS-16090, NCT00085436

23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UARK 2000-46, NCT00083538

24.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: Pro00007616, DUMC-5883-04-6RO, CDR000041079, 8087, NCT00103142

25.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor: NCI, Other
Protocol IDs: CDR0000410830, R21CA091624, UKMC-IRB-0391-F2R, UKMC-CTRF-G-01-009, NCT00103116
1    
New Search